(株)ミズホメディーの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4595/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2020/05/15 | 日証協 | 221,934株 | +10.86% | 26,200株 | -53.95% | 203,071株 | +7.69% | 33,034株 | +16.73% |
2020/05/08 | 日証協 | 200,200株 | +0.1% | 56,900株 | +96.21% | 188,571株 | +0.16% | 28,300株 | +221.59% |
2020/05/01 | 日証協 | 200,000株 | +2.88% | 29,000株 | -9.94% | 188,271株 | +2.39% | 8,800株 | -36.69% |
2020/04/24 | 日証協 | 194,400株 | -0.26% | 32,200株 | +72.19% | 183,871株 | +4.02% | 13,900株 | -62.63% |
2020/04/17 | 日証協 | 194,900株 | -10.27% | 18,700株 | -64.31% | 176,771株 | +4.12% | 37,200株 | +244.44% |
2020/04/10 | 日証協 | 217,200株 | +6.47% | 52,400株 | +34.02% | 169,771株 | +1.74% | 10,800株 | -63.76% |
2020/04/03 | 日証協 | 204,000株 | +5.43% | 39,100株 | -15.55% | 166,871株 | +13.62% | 29,800株 | -32.89% |
2020/03/27 | 日証協 | 193,500株 | -31.16% | 46,300株 | -22.05% | 146,871株 | -14.74% | 44,406株 | +233.88% |
2020/03/19 | 日証協 | 281,100株 | +22.7% | 59,400株 | -18.96% | 172,265株 | -0.94% | 13,300株 | -72.26% |
2020/03/13 | 日証協 | 229,100株 | +15.62% | 73,300株 | +52.76% | 173,901株 | -2.89% | 47,949株 | -29.6% |
2020/03/06 | 日証協 | 198,142株 | -18.49% | 47,984株 | -11.14% | 179,081株 | -8.8% | 68,110株 | +3.83% |
2020/02/28 | 日証協 | 243,100株 | +10.25% | 54,000株 | +3.05% | 196,371株 | +7.21% | 65,600株 | +142.96% |
2020/02/21 | 日証協 | 220,500株 | +50.41% | 52,400株 | -57.63% | 183,171株 | +13.23% | 27,000株 | -58.66% |
2020/02/14 | 日証協 | 146,600株 | +66.21% | 123,681株 | +168.29% | 161,766株 | +30.07% | 65,305株 | +35.82% |
2020/02/07 | 日証協 | 88,200株 | -2.43% | 46,100株 | +118.48% | 124,366株 | +19.16% | 48,081株 | +236.23% |
2020/01/31 | 日証協 | 90,400株 | -5.83% | 21,100株 | +13.8% | 104,366株 | -8.1% | 14,300株 | +72.29% |
2020/01/24 | 日証協 | 96,000株 | -13.14% | 18,541株 | +45.07% | 113,566株 | -8.46% | 8,300株 | -49.08% |
2020/01/17 | 日証協 | 110,519株 | -19.27% | 12,781株 | -76.59% | 124,066株 | -5.9% | 16,300株 | -64.41% |
2020/01/10 | 日証協 | 136,900株 | -58% | 54,600株 | -69.22% | 131,847株 | -56.49% | 45,800株 | +1658.83% |
※株式分割は考慮していませんのでご注意ください。
Page Top